156 related articles for article (PubMed ID: 20348246)
1. Tissue distribution and functional analysis of Sushi domain-containing protein 4.
Tu Z; Cohen M; Bu H; Lin F
Am J Pathol; 2010 May; 176(5):2378-84. PubMed ID: 20348246
[TBL] [Abstract][Full Text] [Related]
2. Sushi domain-containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertase.
Holmquist E; Okroj M; Nodin B; Jirström K; Blom AM
FASEB J; 2013 Jun; 27(6):2355-66. PubMed ID: 23482636
[TBL] [Abstract][Full Text] [Related]
3. The human complement inhibitor Sushi Domain-Containing Protein 4 (SUSD4) expression in tumor cells and infiltrating T cells is associated with better prognosis of breast cancer patients.
Englund E; Reitsma B; King BC; Escudero-Esparza A; Owen S; Orimo A; Okroj M; Anagnostaki L; Jiang WG; Jirström K; Blom AM
BMC Cancer; 2015 Oct; 15():737. PubMed ID: 26480818
[TBL] [Abstract][Full Text] [Related]
4. The Complement Regulator Susd4 Influences Nervous-System Function and Neuronal Morphology in Mice.
Zhu H; Meissner LE; Byrnes C; Tuymetova G; Tifft CJ; Proia RL
iScience; 2020 Mar; 23(3):100957. PubMed ID: 32179479
[TBL] [Abstract][Full Text] [Related]
5. Sushi domain-containing protein 4 binds to epithelial growth factor receptor and initiates autophagy in an EGFR phosphorylation independent manner.
Papadakos KS; Ekström A; Slipek P; Skourti E; Reid S; Pietras K; Blom AM
J Exp Clin Cancer Res; 2022 Dec; 41(1):363. PubMed ID: 36578014
[TBL] [Abstract][Full Text] [Related]
6. Pan-cancer analysis of Sushi domain-containing protein 4 (SUSD4) and validated in colorectal cancer.
Zhong Y; Zheng C; Zhang W; Wu H; Zhang Q; Li D; Ju H; Feng H; Chen Y; Fan Y; Chen W; Wang M; Wang G
Aging (Albany NY); 2024 Apr; 16(7):6417-6444. PubMed ID: 38579174
[TBL] [Abstract][Full Text] [Related]
7. Sushi domain-containing protein 4 controls synaptic plasticity and motor learning.
González-Calvo I; Iyer K; Carquin M; Khayachi A; Giuliani FA; Sigoillot SM; Vincent J; Séveno M; Veleanu M; Tahraoui S; Albert M; Vigy O; Bosso-Lefèvre C; Nadjar Y; Dumoulin A; Triller A; Bessereau JL; Rondi-Reig L; Isope P; Selimi F
Elife; 2021 Mar; 10():. PubMed ID: 33661101
[TBL] [Abstract][Full Text] [Related]
8. The role of complement inhibitors beyond controlling inflammation.
Blom AM
J Intern Med; 2017 Aug; 282(2):116-128. PubMed ID: 28345259
[TBL] [Abstract][Full Text] [Related]
9. Prenatal presentation of Mabry syndrome with congenital diaphragmatic hernia and phenotypic overlap with Fryns syndrome.
Reynolds KK; Juusola J; Rice GM; Giampietro PF
Am J Med Genet A; 2017 Oct; 173(10):2776-2781. PubMed ID: 28817240
[TBL] [Abstract][Full Text] [Related]
10. Craniorachischisis Totalis with Congenital Diaphragmatic Hernia-A Rare Presentation of Fryns Syndrome.
Singh A; Pilli GS; Bannur H
Fetal Pediatr Pathol; 2016; 35(3):192-8. PubMed ID: 27064748
[TBL] [Abstract][Full Text] [Related]
11. Fryns syndrome without diaphragmatic hernia, DOOR syndrome or Fryns-like syndrome? Report on patients from Indian Ocean islands.
Alessandri JL; Cuillier F; Malan V; Brayer C; Grondard M; Jacquemot-Dekkak L; Kieffer-Traversier M; Pierre F; Laurain C; Samperiz S; Tiran-Rajaofera I; Ramful D
Am J Med Genet A; 2014 Mar; 164A(3):648-54. PubMed ID: 24357154
[TBL] [Abstract][Full Text] [Related]
12. Atypical Fryns syndrome: clinical, radiological and pathological findings.
Aygün MS; Sekmenli T; Çiftçi İ; Gökmen Z; Tolu İ; Mutlu-Aygün F
Turk J Pediatr; 2014; 56(1):107-10. PubMed ID: 24827959
[TBL] [Abstract][Full Text] [Related]
13. Expression and characterization of the C345C/NTR domains of complement components C3 and C5.
Thai CT; Ogata RT
J Immunol; 2003 Dec; 171(12):6565-73. PubMed ID: 14662858
[TBL] [Abstract][Full Text] [Related]
14. Fryns syndrome with vertebral defects: a novel association in a Mexican infant.
Salinas-Torres VM; Rivera H
Genet Couns; 2014; 25(1):29-33. PubMed ID: 24783652
[TBL] [Abstract][Full Text] [Related]
15. Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis.
Banda NK; Thurman JM; Kraus D; Wood A; Carroll MC; Arend WP; Holers VM
J Immunol; 2006 Aug; 177(3):1904-12. PubMed ID: 16849503
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 and HIV-2 isolates differ in their ability to activate the complement system on the surface of infected cells.
Marschang P; Gürtler L; Tötsch M; Thielens NM; Arlaud GJ; Hittmair A; Katinger H; Dierich MP
AIDS; 1993 Jul; 7(7):903-10. PubMed ID: 7689323
[TBL] [Abstract][Full Text] [Related]
17. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
Medicus RG; Götze O; Müller-Eberhard HJ
J Exp Med; 1976 Oct; 144(4):1076-93. PubMed ID: 978134
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.
Rooijakkers SH; Wu J; Ruyken M; van Domselaar R; Planken KL; Tzekou A; Ricklin D; Lambris JD; Janssen BJ; van Strijp JA; Gros P
Nat Immunol; 2009 Jul; 10(7):721-7. PubMed ID: 19503103
[TBL] [Abstract][Full Text] [Related]
19. A novel chicken membrane-associated complement regulatory protein: molecular cloning and functional characterization.
Inoue N; Fukui A; Nomura M; Matsumoto M; Nishizawa Y; Toyoshima K; Seya T
J Immunol; 2001 Jan; 166(1):424-31. PubMed ID: 11123320
[TBL] [Abstract][Full Text] [Related]
20. Zebrafish knockout of Down syndrome gene,
Kim OH; Cho HJ; Han E; Hong TI; Ariyasiri K; Choi JH; Hwang KS; Jeong YM; Yang SY; Yu K; Park DS; Oh HW; Davis EE; Schwartz CE; Lee JS; Kim HG; Kim CH
Mol Autism; 2017; 8():50. PubMed ID: 29021890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
